Effects of anti-IL-5 monoclonal antibody on the murine model of nasal allergy

International Archives of Allergy and Immunology

Volumn 116, Issue 1, 1998, Pages 49-52

  Asakura, Kohji ^a   Saito, Hiroko ^a   Watanabe, Masako ^a   Ogasawara, Hideki ^a   Matsui, Toshinori ^a   Kataura, Akikatsu ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti IL 5 monoclonal antibody; Murine model; Nasal allergy

Indexed keywords

ANTIGEN; HISTAMINE; INTERLEUKIN 5; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; EOSINOPHIL; EOSINOPHILIA; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; NOSE ALLERGY; PRIORITY JOURNAL;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; EOSINOPHILIA; HISTAMINE; HISTAMINE H1 ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; NASAL CAVITY; NASAL MUCOSA; NASAL PROVOCATION TESTS; RESPIRATORY HYPERSENSITIVITY; RHINITIS; SNEEZING; TIME FACTORS;

EID: 0031922536     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023924     Document Type: Article

References (17)

1. Durham SR, Ying S, Verney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
2. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH: Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853-3865.
3. Saito H, Asakura K, Ogasawara H, Watanabe M, Kataura A: Topical antigen provocation increases the number of immunoreactive IL-4-, IL-5- and IL-6-positive cells in the nasal mucosa of patients with perennial allergic rhinitis. Int Arch Allergy Immunol 1997;114:81-85.
4. Fujisawa T, Abu-Ghazaleh R, Kita H, Sander-son CJ, Gleich GJ: Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-646.
5. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K: Highly purified murine interleukin 5 (IL-5) stimulates eosinophilic function and prolongs in vivo survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1986;167:1737-1742.
6. Rothenberg M, Peterson J, Stevens RL, Silberstein DS, McKenzie DT, Austen KF, Owen WF: IL-5-dependent conversion of normodense eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 1989;143:2311-2316.
7. Guibenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvanti F, Sullivan L, Zurcher JA, Watnick AS: Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 1992;146:263-265.
8. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvandi F, Sullivan L, Zurcher JA, Watnick AS: Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 1992;146:263-265.
9. Chand N, Harrison JE, Rooney S, Pillar J, Jakubicki R, Nolan K, Diamantis W, Sofia RD: Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: A therapeutic approach. Eur J Pharmacol 1992;211:121-123.
10. Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, Jones H, Watnick AS, Egan RW, Kreutner W, Adams GK: Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993; 148:1623-1627.
11. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvandi F, Sullivan L, Zurcher JA, Watnick AS: Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 1992;146:263-265.
12. Watanabe M, Asakura K, Salto H, Kataura A: Manifestation of nasal allergy in ovalbuminsensitized mice - as compares with mast cell-deficient mice with an immunosuppressive agent. J Otolaryngol Jpn 1996;99:454-463.
13. Harada N, Takahashi T, Matsumoto M, Kinashi T, Ohara J, Kikuchi Y, Koyama N, Severinson E, Yaoita Y, Honjo T, Yamaguchi N, Tominaga A, Takatsu K: Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor II. Proc Natl Sci USA 1987;84:4581-4585.
14. Watanabe M, Asakura K, Saito H, Kataura A: Studies on murine model of nasal allergy. Jpn J Allergol 1996;45:1127-1132.
15. Hirai K, Yamaguchi M, Misaki Y, Takaishi T, Ohta K, Monta Y, Ito K, Miyamoto T: Enhancement of human basophil histamine release by interleukin 5. J Exp Med 1990;172:1525-1528.
16. Van Oosterhout AJM, Ladenius RC, Savelkoul HFJ, Van Ark I, Folkerts G, Delsman KC, Nijkamp FP: Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993;147:548-552.
17. Van Oosterhout AJM, Van Ark I, Folkerts G, Van der Linde HJ, Savelkoul HFJ, Verheyen AKCP, Nijkamp FP: Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am J Respir Crit Care Med 1995;151:177-183.